Biodesix announces new master collaborative research agreement with leading us cancer center

Louisville, colo.--(business wire)--biodesix, inc. (nasdaq: bdsx), a leading diagnostic solutions company with a focus in lung diseases, today announced that it has entered into a new master collaborative research agreement (mcra) with memorial sloan kettering cancer center (msk) under which the teams will collaborate on a development plan for diagnostic tests aimed at improving the treatment of cancer. biodesix will utilize its array of genomics, proteomics, and data mining capabilities with t.
BDSX Ratings Summary
BDSX Quant Ranking